Market research
1GSN.F Novanta Inc
F EUR Technology
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 5B
- P/E ratio
- 91.18
- Analyst target
- 145
- Dividend yield
- Not available
- Beta
- 1.68
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Technology
- Industry
- Scientific & Technical Instruments
- ISIN
- CA67000B1040
- Market cap
- 5B
- P/E ratio
- 91.18
- Analyst target
- 145
- Dividend yield
- Not available
- Beta
- 1.68
About
About Novanta Inc
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; imaging, identification and RFID solutions; advanced motion control solutions; and light engines, and integrated operating room technologies. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is based in Bedford, Massachusetts.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the 1GSN.F discussion.
5 years, 5 months ago
Novanta Inc is currently in a long term uptrend where the price is trading 10.4% above its 200 day moving average.
From a valuation standpoint, the stock is 42.1% cheaper than other stocks from the Technology sector with a price to sales ratio of 7.9.
Novanta Inc's total revenue sank by 7.6% to $147M since the same quarter in the previous year.
Its net income has increased by 37.3% to $13M since the same quarter in the previous year.
Finally, its free cash flow grew by 32.4% to $43M since the same quarter in the previous year.
Based on the above factors, Novanta Inc gets an overall score of 4/5.